The FDA has approved Yesintek (Ustekinumab-kfce), a biosimilar to Stelara (Ustekinumab), for the treatment of various chronic inflammatory diseases.

Firearm injury-related emergency department visit rates increased from 2018 to 2020, then decreased through 2023.

Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness.

More than 72,000 pounds of meat and poultry products made by Yu Shang Food have been recalled. HealthDay News — Listeria illness linked to ready-to-eat meat and poultry products has caused the death ...

From 1999 to 2020, there was a significant approximately twofold increase in alcohol-related mortality in the United States.

Work-time, rather than leisure-time or nonworkday, activity behavior seems to be associated with 24-hour ambulatory blood pressure.

Findings were seen for reduced patterns of both rapid and slow infant growth. HealthDay News — Adhering to a healthy prenatal diet may reduce patterns of infant growth outside reference ranges, ...

Denifanstat treatment significantly improves liver disease activity among individuals with metabolic dysfunction-associated steatohepatitis.

GLP-1RA medications in preadolescents and adolescents were concentrated among those with diabetes, obesity, mood disorders, and anxiety.

Exposure to elexacaftor-tezacaftor-ivacaftor (ETI) is associated with metabolic syndrome (MetSyn) in patients with cystic fibrosis.

Based on the current trajectory, overweight and obesity will continue increasing in the United States up to 2050, according to a study.

Respiratory syncytial virus (RSV) vaccination at least 5 weeks prior to delivery results in the highest transplacental transfer of maternal antibodies to the neonate.